Kaleido BioSciences, Inc. (KLDO:NASDAQ) soared at $7.7, a gain of 34.1%. The stock appeared on our News Catalysts scanner on Thu 09 Jan 20 at 09:19 AM in the 'PATNERSHIP' category. From Tue 31 Dec 19, the stock recorded 64.29% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kaleido BioSciences, Inc. (KLDO:NASDAQ)
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.
Top 10 Gainers:
- Trans World Entertainment Corporation (TWMC:NASDAQ), 206.14%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 79.65%
- NanoViricides, Inc. (NNVC:NYSEMKT), 43.19%
- Innovate Biopharmaceuticals, Inc. (INNT:NASDAQ), 38.57%
- Kaleido BioSciences, Inc. (KLDO:NASDAQ), 34.15%
- eMagin Corporation (EMAN:NYSEMKT), 32.1%
- SLM Corporation (SLM:NASDAQ), 29.26%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 29.25%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 25.73%
- MarineMax, Inc. (HZO:NYSE), 23.98%